{
    "2021-09-03": [
        [
            {
                "time": "2021-09-03",
                "original_text": "上海医药控股股东方面拟增持公司H股股份",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股股东",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-03",
                "original_text": "上海医药(02607)获上实集团增持21.28万股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上实集团",
                        "增持",
                        "21.28万股",
                        "H股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-03",
                "original_text": "上海医药：控股股东增持21.28万股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股股东",
                        "增持",
                        "21.28万股",
                        "H股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-03",
                "original_text": "上海医药(601607.SH)获控股股东增持21.28万股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股股东",
                        "增持",
                        "21.28万股",
                        "H股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}